Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11.

scientific article

Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.OPHTHA.2016.06.025
P932PMC publication ID5077673
P698PubMed publication ID27448832

P50authorEmily ChewQ24266614
Amitha DomalpallyQ42716579
Elvira AgrónQ83234331
Traci E ClemonsQ92993074
Age-Related Eye Disease Study 2 Research GroupQ117242065
Ronald P DanisQ117242070
P2093author name stringBarbara Blodi
P2860cites workGlobal data on visual impairment in the year 2002Q24650312
Automated analysis of digital fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration using confocal scanning laser ophthalmoscopy (cSLO).Q24799845
Prevalence of age-related macular degeneration in the United StatesQ29614964
Analysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degenerationQ30728578
Designing clinical trials for age-related geographic atrophy of the macula: enrollment data from the geographic atrophy natural history studyQ31099429
Issues in quantifying atrophic macular disease using retinal autofluorescenceQ33249400
Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degenerationQ33269883
Evaluation of autofluorescence imaging with the scanning laser ophthalmoscope and the fundus camera in age-related geographic atrophyQ33339189
Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26.Q33502975
The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration.Q33774150
Use of fundus autofluorescence images to predict geographic atrophy progressionQ34580441
Fundus autofluorescence imaging in age-related macular degenerationQ34952682
Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trialQ34956193
Fundus autofluorescence characteristics of nascent geographic atrophy in age-related macular degenerationQ35145864
Comparison of Geographic Atrophy Growth Rates Using Different Imaging Modalities in the COMPLETE StudyQ35630746
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)Q36360812
Scanning laser ophthalmoscopic analysis of the pattern of visual loss in age-related geographic atrophy of the maculaQ36677313
Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt diseaseQ36823629
Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuityQ36886079
The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trialsQ36924781
Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy areaQ36968738
Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)Q36996217
The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye StudyQ37033918
Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degenerationQ37314763
Fundus autofluorescence and progression of age-related macular degenerationQ37378156
Natural History of Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration (Geographic Atrophy Progression Study).Q38945380
Brightness, contrast, and color balance of digital versus film retinal images in the age-related eye disease study 2.Q39843458
Concordance of disease progression in bilateral geographic atrophy due to AMD.Q39902539
The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6.Q43796210
Geographic atrophy of the retinal pigment epitheliumQ44824754
Multimodal evaluation of foveal sparing in patients with geographicatrophy due to age-related macular degenerationQ45167302
Measuring geographic atrophy in advanced age-related macular degeneration.Q51386893
In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristicsQ72631037
Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscopeQ73089239
Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degenerationQ78257646
P433issue11
P921main subjecteye diseaseQ3041498
geographic atrophyQ47200750
P304page(s)2401-2407
P577publication date2016-07-19
P1433published inOphthalmologyQ7098109
P1476titleEvaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11.
P478volume123

Reverse relations

cites work (P2860)
Q90082786Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15
Q89000394Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy
Q49488840MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Q41697555MMP-2 Rs24386 (C-->T) gene polymorphism and the phenotype of age-related macular degeneration
Q56243532Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16
Q92589150Semi-automated quantification of geographic atrophy with blue-light autofluorescence and spectral-domain optical coherence tomography: a comparison between the region finder and the advanced retinal pigment epithelium tool in the clinical setting
Q94400988Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age‐related macular degeneration

Search more.